ASX: TLX
Telix Pharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences · Victoria · $4.6B
Development and commercialising molecularly targeted radiation products for the treatment of cancer.
| ASX code | TLX |
|---|---|
| Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Market capitalisation | $4.6B |
| Listed on ASX | 15/11/2017 |
| Registered office | 55 Flemington Road, NORTH MELBOURNE, VIC, AUSTRALIA, 3051 |
| State | Victoria |
| Phone | 03 3093 3897 |
| Fax | 0 |
| Website | http://www.telixpharma.com ↗ |
Share registry
Shareholders contact the share registry (not the company) for holdings, dividends and address changes.
| Registry | MUFG CORPORATE MARKETS (AU) LIMITED |
|---|---|
| Phone | 1300 554 474 |
| Address | LIBERTY PLACE, LEVEL 41, 161 CASTLEREAGH ST, SYDNEY, NSW, AUSTRALIA, 2000 |